ÂÜÀòÂÒÂ×

The Clinical Development and Operations team at ALX Oncology is responsible for designing, implementing, and managing clinical trials that evaluate the safety and efficacy of innovative cancer therapies targeting the CD47 checkpoint pathway. This team collaborates across various functions to ensure that clinical studies are conducted efficiently, adhere to regulatory standards, and generate reliable data to support the company's mission of advancing immuno-oncology treatments for patients.